Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.55772957 |
2 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.19442984 |
3 | B cell receptor signaling pathway (GO:0050853) | 5.87945981 |
4 | positive regulation of B cell differentiation (GO:0045579) | 5.87090384 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.50219203 |
6 | regulation of B cell differentiation (GO:0045577) | 5.46779777 |
7 | immunoglobulin mediated immune response (GO:0016064) | 5.03439435 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.02011108 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.01042742 |
10 | macrophage activation involved in immune response (GO:0002281) | 4.92555088 |
11 | modulation by symbiont of host immune response (GO:0052553) | 4.86491317 |
12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.86491317 |
13 | modulation by symbiont of host defense response (GO:0052031) | 4.86491317 |
14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.86491317 |
15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.86491317 |
16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.86491317 |
17 | microglial cell activation (GO:0001774) | 4.85664533 |
18 | negative regulation of granulocyte differentiation (GO:0030853) | 4.74403222 |
19 | detection of other organism (GO:0098543) | 4.69410244 |
20 | detection of bacterium (GO:0016045) | 4.58044012 |
21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.55350990 |
22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.55350990 |
23 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.43785604 |
24 | positive regulation of interferon-alpha production (GO:0032727) | 4.33153270 |
25 | negative regulation of interleukin-12 production (GO:0032695) | 4.27125313 |
26 | mature B cell differentiation (GO:0002335) | 4.20539119 |
27 | respiratory burst (GO:0045730) | 4.11185511 |
28 | regulation of interferon-alpha production (GO:0032647) | 4.06960339 |
29 | positive regulation of antigen processing and presentation (GO:0002579) | 4.02584482 |
30 | negative regulation of bone resorption (GO:0045779) | 3.96929660 |
31 | negative regulation of B cell proliferation (GO:0030889) | 3.90628770 |
32 | detection of external biotic stimulus (GO:0098581) | 3.86915635 |
33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.86160350 |
34 | cellular extravasation (GO:0045123) | 3.85412743 |
35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.80623402 |
36 | positive regulation of chemokine secretion (GO:0090197) | 3.79693712 |
37 | macrophage activation (GO:0042116) | 3.72543882 |
38 | germinal center formation (GO:0002467) | 3.66326813 |
39 | response to muramyl dipeptide (GO:0032495) | 3.65119071 |
40 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.64938798 |
41 | defense response to protozoan (GO:0042832) | 3.57917653 |
42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.57810711 |
43 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.56691894 |
44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56629616 |
45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.56205247 |
46 | positive regulation of type 2 immune response (GO:0002830) | 3.55652340 |
47 | negative thymic T cell selection (GO:0045060) | 3.54358776 |
48 | negative regulation of phagocytosis (GO:0050765) | 3.53530086 |
49 | neutrophil activation involved in immune response (GO:0002283) | 3.52206737 |
50 | detection of molecule of bacterial origin (GO:0032490) | 3.51821122 |
51 | myeloid cell activation involved in immune response (GO:0002275) | 3.51555115 |
52 | mature B cell differentiation involved in immune response (GO:0002313) | 3.51473144 |
53 | B cell mediated immunity (GO:0019724) | 3.51132535 |
54 | I-kappaB phosphorylation (GO:0007252) | 3.51097996 |
55 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.47745333 |
56 | detection of biotic stimulus (GO:0009595) | 3.45036168 |
57 | positive regulation of interferon-beta production (GO:0032728) | 3.44086414 |
58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.43551894 |
59 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.42478012 |
60 | B cell homeostasis (GO:0001782) | 3.41562059 |
61 | negative T cell selection (GO:0043383) | 3.36946273 |
62 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.36445944 |
63 | response to peptidoglycan (GO:0032494) | 3.35982979 |
64 | regulation of T cell tolerance induction (GO:0002664) | 3.34541029 |
65 | regulation of gamma-delta T cell activation (GO:0046643) | 3.34427410 |
66 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.34328640 |
67 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.34007084 |
68 | regulation of antigen processing and presentation (GO:0002577) | 3.33788136 |
69 | cellular response to exogenous dsRNA (GO:0071360) | 3.32591561 |
70 | pinocytosis (GO:0006907) | 3.30944154 |
71 | leukocyte aggregation (GO:0070486) | 3.29789004 |
72 | mast cell activation (GO:0045576) | 3.29477701 |
73 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.27923586 |
74 | positive regulation of mast cell degranulation (GO:0043306) | 3.27923586 |
75 | regulation of mast cell degranulation (GO:0043304) | 3.25412414 |
76 | response to protozoan (GO:0001562) | 3.22287380 |
77 | positive thymic T cell selection (GO:0045059) | 3.21524172 |
78 | neutrophil activation (GO:0042119) | 3.20605152 |
79 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.20310108 |
80 | negative regulation of cell killing (GO:0031342) | 3.20310108 |
81 | regulation of tolerance induction (GO:0002643) | 3.20220030 |
82 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.19505692 |
83 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18974535 |
84 | negative regulation of tissue remodeling (GO:0034104) | 3.17123705 |
85 | regulation of B cell proliferation (GO:0030888) | 3.15782009 |
86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15401245 |
87 | T cell selection (GO:0045058) | 3.14121324 |
88 | response to host (GO:0075136) | 3.13827414 |
89 | negative regulation of interleukin-6 production (GO:0032715) | 3.12854426 |
90 | T cell migration (GO:0072678) | 3.12437392 |
91 | activated T cell proliferation (GO:0050798) | 3.11622058 |
92 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.11349110 |
93 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09126539 |
94 | myeloid dendritic cell activation (GO:0001773) | 3.08185877 |
95 | tolerance induction (GO:0002507) | 3.07599982 |
96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05781912 |
97 | negative regulation of bone remodeling (GO:0046851) | 3.05410643 |
98 | response to type I interferon (GO:0034340) | 3.05055398 |
99 | cellular response to zinc ion (GO:0071294) | 3.04464257 |
100 | type I interferon signaling pathway (GO:0060337) | 3.04147746 |
101 | cellular response to type I interferon (GO:0071357) | 3.04147746 |
102 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04121084 |
103 | regulation of leukocyte degranulation (GO:0043300) | 3.03332098 |
104 | positive T cell selection (GO:0043368) | 3.03124402 |
105 | mannose metabolic process (GO:0006013) | 3.02773229 |
106 | B cell proliferation (GO:0042100) | 3.02673216 |
107 | macrophage differentiation (GO:0030225) | 3.01386621 |
108 | regulation of mast cell activation (GO:0033003) | 3.00268934 |
109 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99695441 |
110 | response to host immune response (GO:0052572) | 2.99695441 |
111 | regulation of granulocyte differentiation (GO:0030852) | 2.99114011 |
112 | T-helper 1 type immune response (GO:0042088) | 2.97130243 |
113 | myeloid leukocyte activation (GO:0002274) | 2.96965328 |
114 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.96732650 |
115 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.96636389 |
116 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96379411 |
117 | cellular response to interferon-gamma (GO:0071346) | 2.96222508 |
118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.93753284 |
119 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93744260 |
120 | regulation of B cell apoptotic process (GO:0002902) | 2.93534872 |
121 | positive regulation of mast cell activation (GO:0033005) | 2.91812087 |
122 | adaptation of signaling pathway (GO:0023058) | 2.90822030 |
123 | lymphocyte homeostasis (GO:0002260) | 2.89559376 |
124 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.89255045 |
125 | granulocyte activation (GO:0036230) | 2.88705143 |
126 | regulation of hypersensitivity (GO:0002883) | 2.88632786 |
127 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.88468397 |
128 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87158342 |
129 | natural killer cell differentiation (GO:0001779) | 2.86622996 |
130 | regulation of type 2 immune response (GO:0002828) | 2.85253954 |
131 | positive regulation of B cell activation (GO:0050871) | 2.85226871 |
132 | leukocyte degranulation (GO:0043299) | 2.82286515 |
133 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.82048425 |
134 | positive regulation of interleukin-12 production (GO:0032735) | 2.81799515 |
135 | cellular response to interferon-beta (GO:0035458) | 2.81306528 |
136 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.80109837 |
137 | response to host defenses (GO:0052200) | 2.80109837 |
138 | regulation of interleukin-12 production (GO:0032655) | 2.79833705 |
139 | neutrophil mediated immunity (GO:0002446) | 2.79238066 |
140 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.78916062 |
141 | regulation of germinal center formation (GO:0002634) | 2.78221552 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.10809108 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.09813655 |
3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.07416381 |
4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.85696618 |
5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.82853736 |
6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.72206943 |
7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58040711 |
8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.52872969 |
9 | MYC_22102868_ChIP-Seq_BL_Human | 3.29044680 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.27105929 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.15842799 |
12 | GATA1_22025678_ChIP-Seq_K562_Human | 3.09832518 |
13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08545735 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08231274 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.06392456 |
16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75829398 |
17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.65266981 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.56259361 |
19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.52496635 |
20 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.49333706 |
21 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.46687662 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.44760723 |
23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43919767 |
24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42394149 |
25 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.42234949 |
26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.35921512 |
27 | MYB_26560356_Chip-Seq_TH2_Human | 2.28233912 |
28 | MAF_26560356_Chip-Seq_TH1_Human | 2.26581979 |
29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.26228661 |
30 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.20436696 |
31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17112728 |
32 | MYB_26560356_Chip-Seq_TH1_Human | 2.16654971 |
33 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.15334302 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13661655 |
35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04520612 |
36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02067468 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01291427 |
38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00571631 |
39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91215253 |
40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90612173 |
41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88804426 |
42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83239847 |
43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77614997 |
44 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75195948 |
45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69819437 |
46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68258158 |
47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67258599 |
48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60672886 |
49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59078179 |
50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56650349 |
51 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.56570172 |
52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55680577 |
53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55429567 |
54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51671771 |
55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48568132 |
56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47740285 |
57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44903818 |
58 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41730049 |
59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40290583 |
60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34150565 |
61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31688457 |
62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31658148 |
63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30924895 |
64 | MAF_26560356_Chip-Seq_TH2_Human | 1.28552313 |
65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27865153 |
66 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27726265 |
67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26577106 |
68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26088181 |
69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22501544 |
70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22434835 |
71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22317454 |
72 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22303520 |
73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19066426 |
74 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18872243 |
75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17856041 |
76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13554676 |
77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13432170 |
78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10744311 |
79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10632900 |
80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06570139 |
81 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05430080 |
82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03487263 |
83 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03056749 |
84 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00952985 |
85 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99950098 |
86 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.99906852 |
87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99615465 |
88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95041092 |
89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93737391 |
90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92616485 |
91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91079563 |
92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.90785647 |
93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89498941 |
94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88590993 |
95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87934897 |
96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87599532 |
97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87000767 |
98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85830338 |
99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85269187 |
100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82874696 |
101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81961460 |
102 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80719573 |
103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80299190 |
104 | P300_27268052_Chip-Seq_Bcells_Human | 0.78277779 |
105 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.78123869 |
106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.76518974 |
107 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75913138 |
108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73175950 |
109 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.72908166 |
110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.72871399 |
111 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71613493 |
112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.71444380 |
113 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69524739 |
114 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.68866344 |
115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.68638221 |
116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.68525528 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.38786135 |
2 | MP0001800_abnormal_humoral_immune | 3.47754170 |
3 | MP0001790_abnormal_immune_system | 3.35782254 |
4 | MP0005387_immune_system_phenotype | 3.35782254 |
5 | MP0005671_abnormal_response_to | 3.32553466 |
6 | MP0002452_abnormal_antigen_presenting | 3.12559224 |
7 | MP0003303_peritoneal_inflammation | 3.06071554 |
8 | MP0000685_abnormal_immune_system | 3.02694968 |
9 | MP0005000_abnormal_immune_tolerance | 2.86586262 |
10 | MP0005058_abnormal_lysosome_morphology | 2.82699151 |
11 | MP0002723_abnormal_immune_serum | 2.79867891 |
12 | MP0002419_abnormal_innate_immunity | 2.73684297 |
13 | MP0002420_abnormal_adaptive_immunity | 2.67711294 |
14 | MP0005464_abnormal_platelet_physiology | 2.65930455 |
15 | MP0001819_abnormal_immune_cell | 2.65907749 |
16 | MP0002396_abnormal_hematopoietic_system | 2.65695044 |
17 | MP0003436_decreased_susceptibility_to | 2.51200535 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.43634641 |
19 | MP0005025_abnormal_response_to | 2.43369082 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.43300591 |
21 | MP0003183_abnormal_peptide_metabolism | 2.31509788 |
22 | MP0002398_abnormal_bone_marrow | 2.28749936 |
23 | MP0003172_abnormal_lysosome_physiology | 2.23623991 |
24 | MP0000716_abnormal_immune_system | 2.20194973 |
25 | MP0006082_CNS_inflammation | 2.13439092 |
26 | MP0003300_gastrointestinal_ulcer | 2.12268125 |
27 | MP0009785_altered_susceptibility_to | 2.09387256 |
28 | MP0000689_abnormal_spleen_morphology | 2.08442068 |
29 | MP0001853_heart_inflammation | 1.99526496 |
30 | MP0002405_respiratory_system_inflammati | 1.87335919 |
31 | MP0002429_abnormal_blood_cell | 1.81357539 |
32 | MP0002722_abnormal_immune_system | 1.79391832 |
33 | MP0001845_abnormal_inflammatory_respons | 1.78580825 |
34 | MP0002166_altered_tumor_susceptibility | 1.76749447 |
35 | MP0004808_abnormal_hematopoietic_stem | 1.73259341 |
36 | MP0000465_gastrointestinal_hemorrhage | 1.69950187 |
37 | MP0001873_stomach_inflammation | 1.69192862 |
38 | MP0003763_abnormal_thymus_physiology | 1.66356694 |
39 | MP0009333_abnormal_splenocyte_physiolog | 1.61960495 |
40 | MP0004510_myositis | 1.58045999 |
41 | MP0010155_abnormal_intestine_physiology | 1.55940218 |
42 | MP0005174_abnormal_tail_pigmentation | 1.53235359 |
43 | MP0002928_abnormal_bile_duct | 1.53091674 |
44 | MP0005310_abnormal_salivary_gland | 1.51636705 |
45 | MP0000569_abnormal_digit_pigmentation | 1.49582649 |
46 | MP0008469_abnormal_protein_level | 1.48488635 |
47 | MP0000015_abnormal_ear_pigmentation | 1.42832684 |
48 | MP0003866_abnormal_defecation | 1.41921347 |
49 | MP0009278_abnormal_bone_marrow | 1.29327283 |
50 | MP0000703_abnormal_thymus_morphology | 1.28091522 |
51 | MP0001533_abnormal_skeleton_physiology | 1.25901232 |
52 | MP0004947_skin_inflammation | 1.24137260 |
53 | MP0003045_fibrosis | 1.20535825 |
54 | MP0005451_abnormal_body_composition | 1.19893579 |
55 | MP0008260_abnormal_autophagy | 1.18391421 |
56 | MP0002006_tumorigenesis | 1.17058652 |
57 | MP0003724_increased_susceptibility_to | 1.15119399 |
58 | MP0000371_diluted_coat_color | 1.13826608 |
59 | MP0001545_abnormal_hematopoietic_system | 1.13737431 |
60 | MP0005397_hematopoietic_system_phenotyp | 1.13737431 |
61 | MP0009840_abnormal_foam_cell | 1.11476662 |
62 | MP0008004_abnormal_stomach_pH | 1.11474995 |
63 | MP0006054_spinal_hemorrhage | 1.08517483 |
64 | MP0002095_abnormal_skin_pigmentation | 1.06152405 |
65 | MP0002138_abnormal_hepatobiliary_system | 1.04706782 |
66 | MP0002933_joint_inflammation | 1.00771066 |
67 | MP0002132_abnormal_respiratory_system | 0.99064090 |
68 | MP0000343_altered_response_to | 0.98103610 |
69 | MP0000490_abnormal_crypts_of | 0.94827801 |
70 | MP0004381_abnormal_hair_follicle | 0.91647789 |
71 | MP0002998_abnormal_bone_remodeling | 0.91314183 |
72 | MP0003075_altered_response_to | 0.91310885 |
73 | MP0001851_eye_inflammation | 0.90992093 |
74 | MP0000249_abnormal_blood_vessel | 0.90270775 |
75 | MP0002693_abnormal_pancreas_physiology | 0.88935903 |
76 | MP0001663_abnormal_digestive_system | 0.87736971 |
77 | MP0001986_abnormal_taste_sensitivity | 0.86862547 |
78 | MP0005075_abnormal_melanosome_morpholog | 0.85360763 |
79 | MP0008007_abnormal_cellular_replicative | 0.84131851 |
80 | MP0003828_pulmonary_edema | 0.80857368 |
81 | MP0005670_abnormal_white_adipose | 0.79875107 |
82 | MP0005164_abnormal_response_to | 0.77535227 |
83 | MP0000858_altered_metastatic_potential | 0.76936777 |
84 | MP0005166_decreased_susceptibility_to | 0.75530116 |
85 | MP0003690_abnormal_glial_cell | 0.73910920 |
86 | MP0008057_abnormal_DNA_replication | 0.71922534 |
87 | MP0002277_abnormal_respiratory_mucosa | 0.70641548 |
88 | MP0003806_abnormal_nucleotide_metabolis | 0.70379139 |
89 | MP0002136_abnormal_kidney_physiology | 0.68360965 |
90 | MP0002019_abnormal_tumor_incidence | 0.67905119 |
91 | MP0003252_abnormal_bile_duct | 0.67557229 |
92 | MP0002877_abnormal_melanocyte_morpholog | 0.67266707 |
93 | MP0005167_abnormal_blood-brain_barrier | 0.66196776 |
94 | MP0009763_increased_sensitivity_to | 0.64993172 |
95 | MP0009765_abnormal_xenobiotic_induced | 0.64134110 |
96 | MP0000767_abnormal_smooth_muscle | 0.63845719 |
97 | MP0005390_skeleton_phenotype | 0.63166678 |
98 | MP0001915_intracranial_hemorrhage | 0.62746453 |
99 | MP0003566_abnormal_cell_adhesion | 0.62629083 |
100 | MP0003656_abnormal_erythrocyte_physiolo | 0.62599463 |
101 | MP0008873_increased_physiological_sensi | 0.61939143 |
102 | MP0010307_abnormal_tumor_latency | 0.61815323 |
103 | MP0008874_decreased_physiological_sensi | 0.61199362 |
104 | MP0002009_preneoplasia | 0.61030883 |
105 | MP0003448_altered_tumor_morphology | 0.61023886 |
106 | MP0003195_calcinosis | 0.60010375 |
107 | MP0000609_abnormal_liver_physiology | 0.59046282 |
108 | MP0002332_abnormal_exercise_endurance | 0.58019623 |
109 | MP0003279_aneurysm | 0.57834502 |
110 | MP0009764_decreased_sensitivity_to | 0.57761678 |
111 | MP0003795_abnormal_bone_structure | 0.57445772 |
112 | MP0000604_amyloidosis | 0.55802685 |
113 | MP0009115_abnormal_fat_cell | 0.55473860 |
114 | MP0008058_abnormal_DNA_repair | 0.55472414 |
115 | MP0000598_abnormal_liver_morphology | 0.54118812 |
116 | MP0002075_abnormal_coat/hair_pigmentati | 0.53957003 |
117 | MP0004883_abnormal_blood_vessel | 0.53912345 |
118 | MP0003787_abnormal_imprinting | 0.53911064 |
119 | MP0005535_abnormal_body_temperature | 0.50955276 |
120 | MP0005319_abnormal_enzyme/_coenzyme | 0.50561409 |
121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.46969806 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.83714542 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.81095655 |
3 | Agammaglobulinemia (HP:0004432) | 5.27149438 |
4 | Systemic lupus erythematosus (HP:0002725) | 5.23140458 |
5 | Colitis (HP:0002583) | 5.04490790 |
6 | Optic neuritis (HP:0100653) | 4.67832759 |
7 | Retrobulbar optic neuritis (HP:0100654) | 4.67832759 |
8 | Orchitis (HP:0100796) | 4.61571414 |
9 | IgM deficiency (HP:0002850) | 4.54508661 |
10 | Glomerulonephritis (HP:0000099) | 4.49378107 |
11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.36017079 |
12 | Cellulitis (HP:0100658) | 4.35177534 |
13 | Inflammation of the large intestine (HP:0002037) | 4.33848634 |
14 | Gastrointestinal inflammation (HP:0004386) | 4.24193778 |
15 | Eczematoid dermatitis (HP:0000976) | 4.22852803 |
16 | Recurrent viral infections (HP:0004429) | 4.21518111 |
17 | Stomatitis (HP:0010280) | 4.20269689 |
18 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.08158527 |
19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.08158527 |
20 | Abnormality of glycolipid metabolism (HP:0010969) | 4.08158527 |
21 | Recurrent skin infections (HP:0001581) | 3.89528908 |
22 | Increased cerebral lipofuscin (HP:0011813) | 3.75240349 |
23 | Gastrointestinal infarctions (HP:0005244) | 3.73645686 |
24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.72797957 |
25 | Meningitis (HP:0001287) | 3.61172518 |
26 | Gastrointestinal stroma tumor (HP:0100723) | 3.58513333 |
27 | Panhypogammaglobulinemia (HP:0003139) | 3.54892233 |
28 | Recurrent fungal infections (HP:0002841) | 3.54832627 |
29 | Dysostosis multiplex (HP:0000943) | 3.48524041 |
30 | Recurrent bronchitis (HP:0002837) | 3.46294994 |
31 | Hemoptysis (HP:0002105) | 3.43432400 |
32 | Chronic otitis media (HP:0000389) | 3.36380919 |
33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.31054745 |
34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.31054745 |
35 | Thrombocytosis (HP:0001894) | 3.30507469 |
36 | Vacuolated lymphocytes (HP:0001922) | 3.27811663 |
37 | Keratoconjunctivitis sicca (HP:0001097) | 3.25332911 |
38 | Keratoconjunctivitis (HP:0001096) | 3.10289410 |
39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.07875860 |
40 | Agnosia (HP:0010524) | 3.07614890 |
41 | Urticaria (HP:0001025) | 3.06499037 |
42 | Mediastinal lymphadenopathy (HP:0100721) | 2.99173663 |
43 | Chest pain (HP:0100749) | 2.99131008 |
44 | Spontaneous hematomas (HP:0007420) | 2.97292202 |
45 | Chronic diarrhea (HP:0002028) | 2.96418321 |
46 | Abnormality of T cell physiology (HP:0011840) | 2.96064615 |
47 | Complement deficiency (HP:0004431) | 2.95269428 |
48 | Lymphopenia (HP:0001888) | 2.94898017 |
49 | Interstitial pulmonary disease (HP:0006530) | 2.89562263 |
50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89388890 |
51 | Recurrent sinusitis (HP:0011108) | 2.88645233 |
52 | Osteomyelitis (HP:0002754) | 2.88422005 |
53 | Vasculitis (HP:0002633) | 2.87567432 |
54 | Obstructive lung disease (HP:0006536) | 2.87440741 |
55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87440741 |
56 | Abnormality of macrophages (HP:0004311) | 2.84608481 |
57 | Hematochezia (HP:0002573) | 2.83415077 |
58 | T lymphocytopenia (HP:0005403) | 2.82982532 |
59 | Abnormality of T cell number (HP:0011839) | 2.81951933 |
60 | Spinal cord lesions (HP:0100561) | 2.80462390 |
61 | Syringomyelia (HP:0003396) | 2.80462390 |
62 | Myositis (HP:0100614) | 2.78110435 |
63 | Spondylolisthesis (HP:0003302) | 2.77762318 |
64 | Leukocytosis (HP:0001974) | 2.76468484 |
65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.75403536 |
66 | Disinhibition (HP:0000734) | 2.66439178 |
67 | Recurrent pneumonia (HP:0006532) | 2.66410992 |
68 | Mucopolysacchariduria (HP:0008155) | 2.60465110 |
69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.60465110 |
70 | Abnormality of complement system (HP:0005339) | 2.59161500 |
71 | Increased IgM level (HP:0003496) | 2.57657748 |
72 | Recurrent lower respiratory tract infections (HP:0002783) | 2.56219051 |
73 | Gingival bleeding (HP:0000225) | 2.55151894 |
74 | Verrucae (HP:0200043) | 2.54014159 |
75 | Papilloma (HP:0012740) | 2.54014159 |
76 | Amyloidosis (HP:0011034) | 2.52434869 |
77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.51591010 |
78 | Abnormality of the pleura (HP:0002103) | 2.51531053 |
79 | Pulmonary embolism (HP:0002204) | 2.49808706 |
80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.47864024 |
81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.47864024 |
82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.47864024 |
83 | Abnormal platelet function (HP:0011869) | 2.45747656 |
84 | Impaired platelet aggregation (HP:0003540) | 2.45747656 |
85 | Emphysema (HP:0002097) | 2.45066294 |
86 | Gangrene (HP:0100758) | 2.43470639 |
87 | Abnormality of the fingertips (HP:0001211) | 2.40962130 |
88 | Episodic fever (HP:0001954) | 2.37897350 |
89 | Gingivitis (HP:0000230) | 2.35696022 |
90 | Thoracic kyphosis (HP:0002942) | 2.35054977 |
91 | Anorexia (HP:0002039) | 2.34015574 |
92 | Sepsis (HP:0100806) | 2.32274781 |
93 | Thyroiditis (HP:0100646) | 2.30939119 |
94 | Absent frontal sinuses (HP:0002688) | 2.30060104 |
95 | Abnormality of T cells (HP:0002843) | 2.29958151 |
96 | Granulocytopenia (HP:0001913) | 2.28890873 |
97 | Nephritis (HP:0000123) | 2.26800374 |
98 | Petechiae (HP:0000967) | 2.26417400 |
99 | Skin rash (HP:0000988) | 2.24119241 |
100 | Chronic sinusitis (HP:0011109) | 2.23495918 |
101 | Prolonged bleeding time (HP:0003010) | 2.22985278 |
102 | Periodontitis (HP:0000704) | 2.21367985 |
103 | Abnormality of the prostate (HP:0008775) | 2.19251600 |
104 | Fatigue (HP:0012378) | 2.18435785 |
105 | IgA deficiency (HP:0002720) | 2.17168431 |
106 | Polyneuropathy (HP:0001271) | 2.14548547 |
107 | Increased IgE level (HP:0003212) | 2.14028270 |
108 | Cerebral aneurysm (HP:0004944) | 2.13503800 |
109 | Eosinophilia (HP:0001880) | 2.12484166 |
110 | Autoimmune thrombocytopenia (HP:0001973) | 2.11763243 |
111 | Viral hepatitis (HP:0006562) | 2.11409245 |
112 | Purpura (HP:0000979) | 2.11403283 |
113 | Epistaxis (HP:0000421) | 2.08747766 |
114 | Hypochromic anemia (HP:0001931) | 2.08692917 |
115 | Hypergammaglobulinemia (HP:0010702) | 2.08002375 |
116 | Loss of speech (HP:0002371) | 2.07608866 |
117 | Retinal atrophy (HP:0001105) | 2.07356485 |
118 | Restrictive lung disease (HP:0002091) | 2.07285012 |
119 | Pustule (HP:0200039) | 2.06958535 |
120 | Pulmonary infiltrates (HP:0002113) | 2.04227101 |
121 | IgG deficiency (HP:0004315) | 2.04043402 |
122 | Vertigo (HP:0002321) | 2.02748959 |
123 | Abnormality of the endocardium (HP:0004306) | 2.02490600 |
124 | Cheilitis (HP:0100825) | 2.01422793 |
125 | Leukopenia (HP:0001882) | 2.01001818 |
126 | Abnormality of the thoracic spine (HP:0100711) | 1.97807595 |
127 | Increased serum ferritin (HP:0003281) | 1.96407402 |
128 | Abnormality of the peritoneum (HP:0002585) | 1.96154900 |
129 | Arthralgia (HP:0002829) | 1.95957688 |
130 | Basal ganglia calcification (HP:0002135) | 1.95883814 |
131 | Papilledema (HP:0001085) | 1.95387945 |
132 | Bronchitis (HP:0012387) | 1.94758655 |
133 | Arterial thrombosis (HP:0004420) | 1.94636771 |
134 | Albinism (HP:0001022) | 1.93390406 |
135 | Encephalitis (HP:0002383) | 1.92497699 |
136 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92309385 |
137 | Lymphoma (HP:0002665) | 1.90916483 |
138 | Skin ulcer (HP:0200042) | 1.90152094 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.89103219 |
2 | CSF1R | 3.68425631 |
3 | TGFBR2 | 3.65017441 |
4 | TYK2 | 2.89091400 |
5 | BLK | 2.87298884 |
6 | IRAK3 | 2.73743759 |
7 | RIPK4 | 2.59849399 |
8 | IRAK4 | 2.55637740 |
9 | MAP3K14 | 2.28834338 |
10 | BTK | 2.28133130 |
11 | MAPK15 | 2.27802255 |
12 | KIT | 2.27046180 |
13 | ERN1 | 2.20600961 |
14 | EEF2K | 1.95319090 |
15 | TBK1 | 1.92859277 |
16 | MAP3K13 | 1.88624148 |
17 | SYK | 1.88327980 |
18 | ZAP70 | 1.87435809 |
19 | MAP3K10 | 1.85304359 |
20 | STK10 | 1.83504917 |
21 | IKBKB | 1.82399461 |
22 | CLK1 | 1.80899643 |
23 | JAK3 | 1.72698693 |
24 | JAK1 | 1.72126464 |
25 | PRPF4B | 1.68266302 |
26 | FLT3 | 1.64350569 |
27 | FES | 1.53137365 |
28 | TAOK3 | 1.52124502 |
29 | CSK | 1.50418112 |
30 | HCK | 1.49098749 |
31 | TEC | 1.46546712 |
32 | LYN | 1.45907038 |
33 | MAP2K3 | 1.42813585 |
34 | TAOK1 | 1.22064949 |
35 | MAP3K3 | 1.20961492 |
36 | SIK2 | 1.20638531 |
37 | MAP3K11 | 1.17442996 |
38 | LCK | 1.17218468 |
39 | GRK6 | 1.15857508 |
40 | GRK7 | 1.15388524 |
41 | ITK | 1.13782400 |
42 | IKBKE | 1.10791443 |
43 | CAMK1D | 1.09377868 |
44 | CDC42BPA | 1.09151890 |
45 | CHUK | 1.05126436 |
46 | LRRK2 | 1.01066105 |
47 | MATK | 0.99589304 |
48 | HIPK2 | 0.94038917 |
49 | MAP3K1 | 0.92017666 |
50 | EPHB1 | 0.91116018 |
51 | TSSK6 | 0.91091659 |
52 | IRAK1 | 0.85633562 |
53 | RPS6KA4 | 0.83580729 |
54 | BRD4 | 0.80400800 |
55 | CAMK1G | 0.79855529 |
56 | MARK3 | 0.77897925 |
57 | MAP3K8 | 0.76483557 |
58 | JAK2 | 0.76421283 |
59 | PKN2 | 0.75336644 |
60 | PDK1 | 0.74429236 |
61 | MAPK12 | 0.72921386 |
62 | PAK4 | 0.72521256 |
63 | MARK2 | 0.71851320 |
64 | TESK2 | 0.69356983 |
65 | NEK9 | 0.65424601 |
66 | CDK12 | 0.65234687 |
67 | FYN | 0.62503013 |
68 | PIM1 | 0.62371030 |
69 | PRKD2 | 0.62358986 |
70 | TXK | 0.62127514 |
71 | SIK3 | 0.60584159 |
72 | FRK | 0.58941601 |
73 | CDK19 | 0.58647998 |
74 | PTK2B | 0.58003073 |
75 | MAP3K7 | 0.55975797 |
76 | PASK | 0.55483780 |
77 | MAPKAPK2 | 0.55153388 |
78 | PTK6 | 0.54682315 |
79 | VRK1 | 0.54521542 |
80 | MAPK7 | 0.53275697 |
81 | BMPR2 | 0.52866873 |
82 | YES1 | 0.52031525 |
83 | EPHA3 | 0.50794951 |
84 | SCYL2 | 0.50726083 |
85 | TNK2 | 0.50577551 |
86 | MAPK4 | 0.48352242 |
87 | TAOK2 | 0.48182093 |
88 | PRKCQ | 0.48172009 |
89 | ACVR1B | 0.47518875 |
90 | STK4 | 0.46741843 |
91 | ABL1 | 0.46444211 |
92 | MAPK11 | 0.45953333 |
93 | CDK6 | 0.44067471 |
94 | PIK3CG | 0.42995806 |
95 | EIF2AK3 | 0.42663251 |
96 | RPS6KA6 | 0.42339360 |
97 | CDK9 | 0.42294397 |
98 | PDPK1 | 0.41915986 |
99 | IRAK2 | 0.41634366 |
100 | TRPM7 | 0.41331131 |
101 | DAPK2 | 0.40917362 |
102 | MAP3K5 | 0.40635842 |
103 | STK11 | 0.39016215 |
104 | DYRK1B | 0.37767577 |
105 | ADRBK2 | 0.37188001 |
106 | RPS6KL1 | 0.34049536 |
107 | RPS6KC1 | 0.34049536 |
108 | FGR | 0.33838610 |
109 | KSR2 | 0.33305519 |
110 | FGFR4 | 0.33230398 |
111 | CAMKK2 | 0.32588486 |
112 | RPS6KA2 | 0.31750584 |
113 | PRKCD | 0.31696446 |
114 | FGFR3 | 0.31559533 |
115 | EGFR | 0.30662042 |
116 | CAMKK1 | 0.30251902 |
117 | SGK3 | 0.29712415 |
118 | PRKD1 | 0.29511353 |
119 | SGK2 | 0.29306607 |
120 | ATR | 0.29012318 |
121 | MAPKAPK3 | 0.28684683 |
122 | CAMK4 | 0.28654149 |
123 | MAP2K6 | 0.27998858 |
124 | CCNB1 | 0.27284022 |
125 | MAP3K6 | 0.27279340 |
126 | GRK1 | 0.26925826 |
127 | NLK | 0.26829396 |
128 | CDK4 | 0.26540570 |
129 | MOS | 0.24892619 |
Rank | Gene Set | Z-score |
---|---|---|
1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.09447510 |
2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.43844188 |
3 | Asthma_Homo sapiens_hsa05310 | 3.34422243 |
4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.18362134 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 3.03335318 |
6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.95968242 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.83847538 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.82637941 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75439730 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.64236757 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.63435359 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.36328334 |
13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.22102835 |
14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.06212233 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.04145992 |
16 | Lysosome_Homo sapiens_hsa04142 | 2.00994615 |
17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.93262141 |
18 | Measles_Homo sapiens_hsa05162 | 1.91290406 |
19 | Pertussis_Homo sapiens_hsa05133 | 1.87771111 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.77476047 |
21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68870737 |
22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61646573 |
23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.58291241 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57765471 |
25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56619291 |
26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53947457 |
27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53609752 |
28 | Influenza A_Homo sapiens_hsa05164 | 1.51484806 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46347997 |
30 | Legionellosis_Homo sapiens_hsa05134 | 1.39534224 |
31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.34512679 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34480504 |
33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33458833 |
34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28709484 |
35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28460859 |
36 | Platelet activation_Homo sapiens_hsa04611 | 1.26600262 |
37 | Apoptosis_Homo sapiens_hsa04210 | 1.23223681 |
38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22711019 |
39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22697443 |
40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20384780 |
41 | Shigellosis_Homo sapiens_hsa05131 | 1.16530657 |
42 | Hepatitis B_Homo sapiens_hsa05161 | 1.14002380 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10420062 |
44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07646508 |
45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07523560 |
46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05591957 |
47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04297506 |
48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00294723 |
49 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91495757 |
50 | Salmonella infection_Homo sapiens_hsa05132 | 0.88992293 |
51 | Malaria_Homo sapiens_hsa05144 | 0.88964435 |
52 | Base excision repair_Homo sapiens_hsa03410 | 0.87328357 |
53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81771814 |
54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80584099 |
55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80072226 |
56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78381386 |
57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77764642 |
58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76541117 |
59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75981909 |
60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.75230094 |
61 | Hepatitis C_Homo sapiens_hsa05160 | 0.74557278 |
62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74467984 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73361340 |
64 | ABC transporters_Homo sapiens_hsa02010 | 0.73085588 |
65 | DNA replication_Homo sapiens_hsa03030 | 0.69169343 |
66 | Mismatch repair_Homo sapiens_hsa03430 | 0.69113629 |
67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68158613 |
68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67064975 |
69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63930530 |
70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62630376 |
71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62103234 |
72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57621146 |
73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55743357 |
74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55226340 |
75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54989909 |
76 | Prion diseases_Homo sapiens_hsa05020 | 0.54971338 |
77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54835171 |
78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.54646332 |
79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53880198 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.53597190 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.52529701 |
82 | Phagosome_Homo sapiens_hsa04145 | 0.50998245 |
83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50322038 |
84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49990208 |
85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49315470 |
86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45805720 |
87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45703372 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43835056 |
89 | Lysine degradation_Homo sapiens_hsa00310 | 0.42846511 |
90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42675236 |
91 | Homologous recombination_Homo sapiens_hsa03440 | 0.42281809 |
92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41034284 |
93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40529228 |
94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39654970 |
95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38828880 |
96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36275687 |
97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34429923 |
98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33712091 |
99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33668794 |
100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32384825 |
101 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.31482582 |
102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31436835 |
103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30902473 |
104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30823612 |
105 | Allograft rejection_Homo sapiens_hsa05330 | 0.30350937 |
106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29677533 |
107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29525013 |
108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28153418 |
109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28060801 |
110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27590932 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26275137 |
112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.25057807 |
113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24332590 |
114 | Protein export_Homo sapiens_hsa03060 | 0.24070825 |
115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24042628 |
116 | Amoebiasis_Homo sapiens_hsa05146 | 0.23621430 |
117 | Prostate cancer_Homo sapiens_hsa05215 | 0.23289237 |
118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22664601 |
119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22037733 |
120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21685689 |
121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.21657890 |
122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20992632 |